Cite

HARVARD Citation

    Hata, H. et al. (2022). A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors. Cancer control. p. . [Online]. 
  
Back to record